Publications

Student opening books in library
Lewis K. Mercer, Emma F. Harding, Grace J. H. Yan, Peter A. White/Wiley Online Library

2022

2021

2020

  • Eyre NS, Kirby EN, Anfiteatro DR, Bracho G, Russo AG, White PA, Alola AL, Beard MR. 2020. Identification of Estrogen Receptor Modulators as Inhibitors of Flavivirus Infection. Antimicrobial Agents and Chemotherapy 64:8.
  • Helbig, K.J.; Bull, R.A.; Ambrose, R.; Beard, M.R.; Blanchard, H.; Böcking, T.; Chua, B.; Colmant, A.M.G.; Crosse, K.M.; Purcell, D.F.J.; Fraser, J.; Hayward, J.A.; Hamilton, S.T.; Husain, M.; MacDiarmid, R.; Mackenzie, J.M.; Moseley, G.W.; Nguyen, T.H.O.; Quiñones-Mateu, M.E.; Robinson, K.; Rodrigo, C.; Rodriguez-Andres, J.; Rudd, P.A.; Werno, A.; White, P.; Young, P.; Speck, P.; Hibma, M.; Drummer, H.E.; Tachedjian, G. 2020. Tenth Scientific Biennial Meeting of the Australasian Virology Society—AVS10 2019. Viruses 12, 621.

2019

  • Vinjé J, Estes MK, Esteves P, Green KY, Katayama K, Knowles NJ, L’Homme Y, Martella V, Vennema H, White PA, Consortium IR. 2019. ICTV Virus Taxonomy Profile: Caliciviridae. Journal of General Virology. 100:1469-1470.
  • Chhabra P, de Graaf M, Parra GI, Chan MC-W, Green K, Martella V, Wang Q, White PA, Katayama K, Vennema H, Koopmans MPG, Vinjé J. 2019. Updated classification of norovirus genogroups and genotypes. Journal of General Virology. 100:1393-1406.
  • Russo AG, Kelly AG, Enosi Tuipulotu D, Tanaka MM, White PA. 2019. Novel insights into endogenous RNA viral elements in Ixodes scapularis and other arbovirus vector genomes. Virus Evolution 5:vez010.
  • Enosi Tuipulotu D, Fumian TM, Netzler NE, Mackenzie JM, White PA. 2019. The adenosine analogue NITD008 has potent antiviral activity against human and animal caliciviruses. Viruses 11:496.
  • Netzler NE, Enosi Tuipulotu D, White PA. 2019. Norovirus antivirals: Where are we now? Medicinal Research Reviews 39:860.
  • Lun JH, Crosbie ND, White PA. 2019. Genetic diversity and quantification of human mastadenoviruses in wastewater from Sydney and Melbourne, Australia. Science of The Total Environment 675:305.
  • Netzler NE, Tuipulotu DE, Vasudevan SG, Mackenzie JM, White PA. 2019. Antiviral candidates for treating hepatitis E virus infection. Antimicrobial Agents and Chemotherapy. 63:e00003-19.
  • Fumian TM, Fioretti JM, Lun JH, dos Santos IAL, White PA, Miagostovich MP. 2019. Detection of norovirus epidemic genotypes in raw sewage using next generation sequencing. Environment International, 123:282.
  • Fritzlar S, White PA, Mackenzie JM. 2019. The microtubule-associated innate immune sensor GEF-H1 does not influence mouse norovirus replication in murine macrophages. Viruses 11:47.

2018

  • Lun JH, Hewitt J, Yan GJH, Tuipulotu DE, Rawlinson WD, White PA. 2018. Recombinant GII.P16/GII.4 Sydney 2012 was the dominant norovirus identified in Australia and New Zealand in 2017. Viruses 10:548.
  • Fumian TM, Tuipulotu DE, Netzler NE, Lun JH, Russo AG, Yan GJH, White PA. 2018. Potential therapeutic agents for feline calicivirus infection. Viruses 10:433 
  • Russo AG, Eden J-S, Tuipulotu DE, Shi M, Selechnik D, Shine R, Rollins LA, Holmes EC, White PA. 2018. Viral discovery in the invasive Australian cane toad (Rhinella marina) using metatranscriptomic and genomic approaches. Journal of Virology 92:17 e00768-18.
  • Edwards RJ, Tuipulotu DE, Amos TG, O’Meally D, Richardson MF, Russell TL, Vallinoto M, Carneiro M, Ferrand N, Wilkins MR, Sequeira F, Rollins LA, Holmes EC, Shine R, White PA. 2018. Draft genome assembly of the invasive cane toad, Rhinella marina. GigaScience 7:giy095.

  • Fritzlar S, Jegaskanda S, Aktepe TE, Prier JE, Holz LE, White PA, Mackenzie JM. 2018. Mouse norovirus infection reduces the surface expression of MHC class I proteins and inhibits CD8+ T cell recognition and activation. Journal of Virology 92:18 e00286-18.

  • Lopez-Denman AJ, Russo AG, Wagstaff KM, White PA, Jans DA, Mackenzie JM. 2018. Nucleocytoplasmic shuttling of the West Nile virus RNA-dependent RNA polymerase NS5 is critical to infection. Cell Microbiology 20:e12848.

  • Jones BJ, Flint J, Collins J, White PA, Lun JH, Durrheim DN. 2018. Gastroenteritis outbreak at a health function caused by an emerging recombinant strain of Norovirus GII.P16/GII.4 Sydney 2012, Australia. Epidemiology and Infection 146:970.

  • Lun JH, Hewitt J, Sitabkhan A, Eden J-S, Enosi Tuipulotu D, Netzler NE, Morrell L, Merif J, Jones R, Huang B, Warrilow D, Ressler K-A, Ferson MJ, Dwyer DE, Kok J, Rawlinson WD, Deere D, Crosbie ND, White PA. 2018. Emerging recombinant noroviruses identified by clinical and waste water screening. Emerging Microbes and Infections 7:50.

  • Tuipulotu DE, Netzler NE, Lun JH, Mackenzie JM, White PA. 2018. TLR7 agonists display potent antiviral effects against norovirus infection via innate stimulation. Antimicrobial Agents and Chemotherapy 62:e02417-17.
  • Ferla S, Netzler NE, Ferla S, Veronese S, Tuipulotu DE, Guccione S, Brancale A, White PA, Bassetto M. 2018. In silico screening for human norovirus antivirals reveals a novel non-nucleoside inhibitor of the viral polymerase. Scientific Reports 8:4129.

2017

  • Lun JH, Ressler KA, Ferson MJ, White PA. 2017. Norovirus and cruise ships. Microbiology Australia 38:4 187.
  • Doerflinger SY, Cortese M, Romero-Brey I, Menne Z, Tubiana T, Schenk C, White PA, Bartenschlager R, Bressanelli S, Hansman GS, Lohmann V. 2017. Membrane alterations induced by nonstructural proteins of human norovirus. PLoS Pathogens 13:e1006705.
  • Tuipulotu DE, Netzler NE, Lun JH, Mackenzie JM, White PA. 2017. RNA-sequencing of murine norovirus infected cells reveals transcriptional alteration of genes important to viral recognition and antigen presentation. Frontiers in Immunology 8:959. 
  • Netzler NE, Enosi Tuipulotu D, Eltahla AA, Lun JH, Ferla S, Brancale A, Urakova N, Frese M, Strive T, Mackenzie JM, White PA. 2017. Broad-spectrum non-nucleoside inhibitors for caliciviruses. Antiviral Research 146:65.
  • Urakova N, Warden AC, White PA, Strive T, Frese M. 2017. A motif in the F homomorph of rabbit haemorrhagic disease virus polymerase is important for the subcellular localisation of the protein and its ability to induce redistribution of golgi membranes. Viruses 9:202.
  • Eden JS, Chisholm RH, Bull RA, White PA, Holmes EC, Tanaka MM. 2017. Persistent infections in immunocompromised hosts are rarely sources of new pathogen variants. Virus Evolution 3:2.
  • Chan MCW, Hu Y, Chen H, Podkolzin AT, Zaytseva EV, Komano J, Sakon N, Poovorawan Y, Vongpunsawad S, Thanusuwannasak T, Hewitt J, Croucher D, Collins N, Vinjé J, Pang XL, Lee BE, de Graaf M, van Beek J, Niendorf S, Poljsak-Prijatelj M, Steyer A, White PA, Lun JH, Mans J, Hung TN, Kwok K, Cheung K, Lee N, Chan PKS. 2017. Global spread of norovirus GII.17 Kawasaki 308, 2014–2016. Emerging Infectious Diseases 23:8 1350.
  • Cotton BT, Hyde JL, Sarvestani ST, Sosnovtsev SV, Green KY, White PA, Mackenzie JM. 2017. The norovirus NS3 protein is a dynamic lipid- and microtubule-associated protein involved in viral RNA replication. Journal of Virology 91:3.

2016

  • White PA, Netzler NE, Hansman GS. 2016. Foodborne Viral Pathogens. CRC Press - Taylor & Francis, Boca Raton, FL.
  • Urakova N, Netzler N, Kelly AG, Frese M, White PA, Strive T. 2016. Purification and biochemical characterisation of rabbit calicivirus RNA-dependent RNA polymerases and identification of non-nucleoside inhibitors. Viruses 8:100.
  • Kelly AG, Netzler NE, White PA. 2016. Ancient recombination events and the origins of hepatitis E virus. BMC Evolutionary Biology 16:1-18.
  • Netzler NE, Kelly AG, White PA. 2016. Hepatitis E virus, an etiological agent of foodborne and waterborne hepatitis. In White PA, Netzler NE, Hansman GS (ed), Foodborne Viral Pathogens. CRC Press - Taylor & Francis, Boca Raton, FL.
  • Lim KL, Netzler NE, Hansman GS, Mackenzie JM, White PA. 2016. Norovirus and Sapovirus. In White PA, Netzler NE, Hansman GS (ed), Foodborne Viral Pathogens. CRC Press - Taylor & Francis, Boca Raton, FL.
  • Lim KL, Hewitt J, Sitabkhan A, Eden J-S, Lun J, Levy A, Merif J, Smith D, Rawlinson WD, White PA. 2016. A multi-site study of norovirus molecular epidemiology in Australia and New Zealand, 2013-2014. PloS One 11:e0145254.

2015

  • Lim KL, Sitabkhan A, Lun J, Levy A, Smith D, White PA. 2015. An update of norovirus epidemiology in Australia, 2013–2014. Journal of Clinical Virology. 70:S51.
  • Koromyslova AD, White PA, Hansman GS. 2015. Treatment of norovirus particles with citrate. Virology 485:199-204.
  • Eltahla AA, Luciani F, White PA, Lloyd AR, Bull RA. 2015. Inhibitors of the hepatitis C virus polymerase; mode of action and resistance. Viruses 7:5206-5224.
  • de Graaf M, van Beek J, Vennema H, Podkolzin AT, Hewitt J, Bucardo F, Templeton K, Mans J, Nordgren J, Reuter G, Lynch M, Rasmussen LD, Iritani N, Chan MC, Martella V, Ambert-Balay K, Vinje J, White PA, Koopmans MP. 2015. Emergence of a novel GII.17 norovirus - end of the GII.4 era? Euro Surveillance 20:1-8.
  • Castro TX, Cubel Garcia Rde C, Fumian TM, Costa EM, Mello R, White PA, Leite JP. 2015. Detection and molecular characterization of caliciviruses (vesivirus and norovirus) in an outbreak of acute diarrhea in kittens from Brazil. The Veterinary Journal 206:115-117.
  • Bretana NA, Boelen L, Bull R, Teutsch S, White PA, Lloyd AR, Luciani F, HITS-p investigators. 2015. Transmission of hepatitis C virus among prisoners, Australia, 2005-2012. Emerging Infectious Disease 21:765.
  • Alhammad YM, Maharajh S, Butcher R, Eden JS, White PA, Poumbourios P, Drummer HE. 2015. Longitudinal sequence and functional evolution within glycoprotein E2 in hepatitis C virus genotype 3a infection. PLoS One 10:e0126397.

2014

  • White PA. 2014. Evolution of norovirus. Clinical Microbiology and Infection 20:741-745.
  • Hartfield M, Bull R, White PA, Lloyd A, Luciani F, Alizon S, and on behalf of the HITS-p investigators. 2014. Evidence that hepatitis C virus genome partly controls infection outcome. Evolutionary Applications 7:533.
  • Hamblin SR, White PA, Tanaka MM. 2014. Viral niche construction alters hosts and ecosystems at multiple scales. Trends in Ecology and Evolution 29:594.
  • Fitzgerald TL, Merritt TD, Zammit A, McLeod C, Landinez LM, White PA, Munnoch SA, Durrheim DN. 2014. An outbreak of norovirus genogroup II associated with New South Wales oysters. Communicable Diseases Intelligence Quarterly Report 38:E9-E15.
  • Eltahla AA, Tay E, Douglas MW, White PA. 2014. Cross-genotypic examination of hepatitis C virus polymerase inhibitors reveals a novel mechanism of action for thumb binders. Antimicrobial Agents and Chemotherapy 58:7215.
  • Eltahla AA, Lim KL, Eden JS, Kelly AG, Mackenzie JM, White PA. 2014. Non-nucleoside inhibitors of norovirus RNA polymerase: scaffolds for rational drug design. Antimicrobial Agents and Chemotherapy 58:3115.
  • Eden JS, Hewitt J, Lim KL, Boni MF, Merif J, Greening G, Ratcliff RM, Holmes EC, Tanaka MM, Rawlinson WD, White PA. 2014. The emergence and evolution of the novel epidemic norovirus GII.4 variant Sydney 2012. Virology 450-451:106.
  • Beard MR, Ffrench R, Gowans EJ, Helbig KJ, Eyre NM, Douglas MM, Grebely J, Ahlenstiel G, Locarnini S, George J, Shackel NA, White PA, Thompson AJ, Drummer HE. 2014. A summary of the 20th International Symposium on Hepatitis C Virus and Related Viruses. Gastroenterology 147:e1-4.

2013

  • Van Beek J, Ambert-Balay K, Botteldoorn N, Eden JS, Fonager J, Hewitt J, Iritani N, Kroneman A, Vennema H, Vinje J, White PA, Koopmans M, NoroNet. 2013. Indications for worldwide increased norovirus activity associated with emergence of a new variant of genotype II.4, late 2012. Euro Surveillance 18:8-9.
  • Sugden PB, Pham TN, Ratnarajah S, Cameron B, Bull R, White PA, Michalak TI, Lloyd AR, and on behalf of the HITS-p investigators. 2013. Rare occurrence of occult hepatitis C virus in apparently uninfected injecting drug users: a two-centre, masked, case-control study. Journal of Viral Hepatitis 20:725-728.
  • Lim KL, Eden JS, Oon LL, White PA. 2013. Molecular epidemiology of norovirus in Singapore, 2004-2011. Journal of Medical Virology 85:1842-1851.
  • Kroneman A, Vega E, Vennema H, Vinje J, White PA, Hansman G, Green K, Martella V, Katayama K, Koopmans M. 2013. Proposal for a unified norovirus nomenclature and genotyping. Archives of Virology 158:2059-2068.
  • Flynn JK, Dore GJ, Hellard M, Yeung B, Rawlinson WD, White PA, Kaldor JM, Lloyd AR, Ffrench RA, ATAHC Study Group. 2013. Maintenance of Th1 hepatitis C virus (HCV)-specific responses in individuals with acute HCV who achieve sustained virological clearance after treatment. Journal of Gastroenterology and Hepatology 28:1770-1781.
  • Eltahla AA, Lackovic K, Marquis C, Eden JS, White PA. 2013. A fluorescence-based high-throughput screen to identify small compound inhibitors of the genotype 3a hepatitis C virus RNA polymerase. Journal of Biomolecular Screening 18:1027-1034.
  • Eden JS, Tanaka MM, Boni MF, Rawlinson WD, White PA. 2013. Recombination within the pandemic norovirus GII.4 lineage. Journal of Virology 87:6270-6282.

2012

  • White PA, Eden J-S, Hansman G. 2012. Molecular epidemiology of noroviruses and sapoviruses and their role in Australian outbreaks of acute gastroenteritis. Microbiology Australia 33:70-73.
  • Sugden PB, Cameron B, Bull R, White PA, Lloyd AR. 2012. Occult infection with hepatitis C virus: friend or foe? Immunology and Cell Biology 90:763-773.
  • Grebely J, Pham ST, Matthews GV, Petoumenos K, Bull RA, Yeung B, Rawlinson W, Kaldor J, Lloyd A, Hellard M, Dore GJ, White PA, ATAHC Study Group. 2012. Hepatitis C virus reinfection and superinfection among treated and untreated participants with recent infection. Hepatology 55:1058-1069.
  • Gouklani H, Bull RA, Beyer C, Coulibaly F, Gowans EJ, Drummer HE, Netter HJ, White PA, Haqshenas G. 2012. Hepatitis C virus nonstructural protein 5B is involved in virus morphogenesis. Journal of Virology 86:5080-5088.
  • Flynn JK, Dore GJ, Matthews G, Hellard M, Yeung B, Rawlinson WD, White PA, Kaldor JM, Lloyd AR, Ffrench RA, ATAHC Study Group. 2012. Impaired hepatitis C virus (HCV)-specific interferon-gamma responses in individuals with HIV who acquire HCV infection: correlation with CD4(+) T-cell counts. The Journal of Infectious Diseases 206:1568-1576.
  • Eden JS, Lim KL, White PA. 2012. Complete genome of the human norovirus GIV.1 strain Lake Macquarie virus. Journal of Virology 86:10251-10252.
  • Bull RA, Eden JS, Luciani F, McElroy K, Rawlinson WD, White PA. 2012. Contribution of intra- and interhost dynamics to norovirus evolution. Journal of Virology 86:3219-3229.

2011

  • Smedley EJ, Stelzer-Braid S, Ressler KA, Melling P, Bowden S, McCaw R, White PA, Vickers CR, Rawlinson WD, Ferson MJ. 2011. Transmission of hepatitis C virus to recipients of parenteral vitamin therapy in a primary care facility. Journal of Clinical Virology 51:105-109.
  • Matthews GV, Pham ST, Hellard M, Grebely J, Zhang L, Oon A, Marks P, van Beek I, Rawlinson W, Kaldor JM, Lloyd A, Dore GJ, White PA, ATAHC Study Group. 2011. Patterns and characteristics of hepatitis C transmission clusters among HIV-positive and HIV-negative individuals in the Australian trial in acute hepatitis C. Clinical Infectious Diseases 52:803-811.
  • Flynn JK, Dore GJ, Hellard M, Yeung B, Rawlinson WD, White PA, Kaldor JM, Lloyd AR, Ffrench RA, ATAHC Study Group. 2011. Early IL-10 predominant responses are associated with progression to chronic hepatitis C virus infection in injecting drug users. Journal of Viral Hepatitis 18:549-561.
  • Eden JS, Sharpe LJ, White PA, Brown AJ. 2011. Norovirus RNA-dependent RNA polymerase is phosphorylated by an important survival kinase, Akt. Journal of Virology 85:10894-10898.
  • Bull RA, White PA. 2011. Mechanisms of GII.4 norovirus evolution. Trends in Microbiology 19:233-240.
  • Bull RA, Luciani F, McElroy K, Gaudieri S, Pham ST, Chopra A, Cameron B, Maher L, Dore GJ, White PA, Lloyd AR. 2011. Sequential bottlenecks drive viral evolution in early acute hepatitis C virus infection. PLoS Pathogens 7:e1002243.
  • Bull RA, Hyde J, Mackenzie JM, Hansman GS, Oka T, Takeda N, White PA. 2011. Comparison of the replication properties of murine and human calicivirus RNA-dependent RNA polymerases. Virus Genes 42:16-27.

2010

  • Tong WW, McAllister J, White PA, Kelleher AD, Carr A. 2010. Transmission of triple-class, drug-resistant HIV-1 in Australia. Internal Medicine Journal 40:657-661.
  • Revill P, Bowden D, White PA. 2010. Viral genotyping and the sequencing revolution, p 40-58. In Jerome K (ed), Lennette's Laboratory Diagnosis of Viral Infections 4th ed New York: Informa Healthcare USA Inc. CRC Press, Boca Raton, FL.
  • Post V, White PA, Hall RM. 2010. Evolution of AbaR-type genomic resistance islands in multiply antibiotic-resistant Acinetobacter baumannii. Journal of Antimicrobial Chemotherapy 65:1162-1170.
  • Pham ST, Bull RA, Bennett JM, Rawlinson WD, Dore GJ, Lloyd AR, White PA. 2010. Frequent multiple hepatitis C virus infections among injection drug users in a prison setting. Hepatology 52:1564-1572.
  • Eden JS, Bull RA, Tu E, McIver CJ, Lyon MJ, Marshall JA, Smith DW, Musto J, Rawlinson WD, White PA. 2010. Norovirus GII.4 variant 2006b caused epidemics of acute gastroenteritis in Australia during 2007 and 2008. Journal of Clinical Virology 49:265-271.
  • Dore GJ, Hellard M, Matthews GV, Grebely J, Haber PS, Petoumenos K, Yeung B, Marks P, van Beek I, McCaughan G, White PA, French R, Rawlinson W, Lloyd AR, Kaldor JM. 2010. Effective treatment of injecting drug users with recently acquired hepatitis C virus infection. Gastroenterology 138:123-135 e121-122.
  • Bull RA, White PA. 2010. Genome organization and recombination, p 45-63. InHansman GS, Jiang XJ, Green KY (ed), Caliciviruses: molecular and cellular virology. Horizon Scientific Press.
  • Bull RA, Eden JS, Rawlinson WD, White PA. 2010. Rapid evolution of pandemic noroviruses of the GII.4 lineage. PLoS Pathogens 6:e1000831.

2009

  • van de Laar T, Pybus O, Bruisten S, Brown D, Nelson M, Bhagani S, Vogel M, Baumgarten A, Chaix ML, Fisher M, Gotz H, Matthews GV, Neifer S, White PA, Rawlinson W, Pol S, Rockstroh J, Coutinho R, Dore GJ, Dusheiko GM, Danta M. 2009. Evidence of a large, international network of HCV transmission in HIV-positive men who have sex with men. Gastroenterology 136:1609-1617.
  • Siebenga JJ, Vennema H, Zheng DP, Vinje J, Lee BE, Pang XL, Ho EC, Lim W, Choudekar A, Broor S, Halperin T, Rasool NB, Hewitt J, Greening GE, Jin M, Duan ZJ, Lucero Y, O'Ryan M, Hoehne M, Schreier E, Ratcliff RM, White PA, Iritani N, Reuter G, Koopmans M. 2009. Norovirus illness is a global problem: emergence and spread of norovirus GII.4 variants, 2001-2007. The Journal of Infectious Diseases 200:802-812.
  • McIver CJ, Rismanto N, Smith C, Naing ZW, Rayner B, Lusk MJ, Konecny P, White PA, Rawlinson WD. 2009. Multiplex PCR testing detection of higher-than-expected rates of cervical mycoplasma, ureaplasma, and trichomonas and viral agent infections in sexually active Australian women. Journal of Clinical Microbiology 47:1358-1363.
  • Matthews GV, Hellard M, Haber P, Yeung B, Marks P, Baker D, McCaughan G, Sasadeusz J, White P, Rawlinson W, Lloyd A, Kaldor J, Dore GJ, Australian Trial in Acute Hepatitis CSG. 2009. Characteristics and treatment outcomes among HIV-infected individuals in the Australian Trial in Acute Hepatitis C. Clinical Infectious Diseases 48:650-658.
  • Mak JK, Kim MJ, Pham J, Tapsall J, White PA. 2009. Antibiotic resistance determinants in nosocomial strains of multidrug-resistant Acinetobacter baumannii. Journal of Antimicrobial Chemotherapy 63:47-54.
  • Dore GJ, Hellard M, Matthews G, Grebely J, Haber PS, Petoumenos K, Yeung B, Marks P, van Beek I, McCaughan G. 2009. Treatment of recent hepatitis C virus infection in a predominantly injecting drug user cohort: the ATAHC Study. Gastroenterology.